Pharmacoepidemiology of Furosemide in the Neonatal Intensive Care Unit
Clicks: 287
ID: 273053
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
287 views
26 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #9 of 28 articles by views in neonatology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background: Furosemide is commonly used off-label in the neonatal intensive care unit (NICU), but current dosing practices vary widely. Objectives: To describe dosing practices including route, dose, and duration of exposure to furosemide in a large number of community and tertiary NICUs across North America. Method: Using the Pediatrix Medical Gro
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (51 words).
Try re-searching for a better abstract.
| Reference Key |
thompson2020neonatologypharmacoepidemiology
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Elizabeth J. Thompson;Daniel K. Benjamin;Rachel G. Greenberg;Karan R. Kumar;Kanecia O. Zimmerman;Matthew Laughon;Reese H. Clark;P. Brian Smith;Christoph P. Hornik; |
| Journal | neonatology |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.